Palace hails stem-cell therapy for COVID-19

July 24, 2020

MALACANANG on Friday hailed The Medical City for its mesenchymal stem treatment for pneumonia patients with the coronavirus disease (COVID-19).

“The Palace commends The Medical City for its mesenchymal stem cell therapy program for patients with COVID-19 pneumonia,” Presidential Spokesperson Harry Roque said in a press statement.

Mesenchymal stem cells (MSCs) are multipotent cells that are being clinically explored as a new therapeutic for treating a variety of immune-mediated diseases, the Washington-based National Center for Biotechnology Information (NCBI) said in its official website.

Since the outbreak of COVID-19, some clinical trials to evaluate the effectiveness and safety of MSC therapy in treating infected individuals have begun.

Currently, there are no approved MSC-based approaches for the prevention or treatment of COVID-19 patients, the NCBI said.

Roque, nevertheless, said the Duterte government backs any move that would help COVID-19 patients recover from the disease.

“The Duterte Administration fully supports researches and/or practices that would ease the sufferings of patients from COVID-19. We fervently pray that the aforesaid program would continue to show promising results,” Roque said.

As of Thursday, the Philippines has recorded 74,390 COVID-19 infections.

Around 24,383 individuals have already recovered from the highly-contagious disease, while 1,871 COVID-19 patients have died.

Roque assured the public anew that the government is doing its best to stop the further transmission of COVID-19 in the country.

“The battle against Covid-19 remains our focus. Let us stand united in defeating this enemy so together we can heal and recover as one,” he said. PNA